In sum, our results suggest that Cxcl9 and Il12b cDC1s are enriched in different regions of the tumour, with Cxcl9 cDC1s preferentially located in the parenchyma and the Il12b cDC1s in tumour border regions (Figure 4D). This evidence concerns the gene CXCL9 and neoplasm.